Published in Cancer Weekly, March 9th, 2004
"Our first objective was to assess changes in nonattendance, proportion of advanced breast cancer and survival in Malmo Mammographic Service Screening Program, MMSSP, compared to a former trial, Malmo Mammographic Screening Trial, MMST. Our second objective was to describe non-attenders in MMSSP in socio-economic terms and risk for advanced breast cancer compared to attenders," scientists writing in the International Journal of Cancer report.
"Information from hospital and national...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.